Applovin Corporation vs Inovio Pharmaceuticals Inc — how do they compare? Applovin Corporation trades at $321.4 (market cap $106.65B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: Applovin Corporation is far larger — about 1357.7× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| APP | INO | |
|---|---|---|
Market Cap | $106.65B | $78.55M |
Sector | Technology | Health |
52-Week High | $733.60 | $2.87 |
52-Week Low | $318.68 | $0.66 |
Enterprise Value | $107.11B | $49.56M |
Trailing returns across standard periods
Latest headlines on both assets
AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.
Read more on APP →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →